Galmed Pharma (GLMD) Tops Q2 EPS by 2c
Galmed Pharma (NASDAQ: GLMD) reported Q2 EPS of ($0.20), $0.02 better than the analyst estimate of ($0.22).Financial Summary - Second ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)